vs

Side-by-side financial comparison of DuPont (DD) and Invesco (IVZ). Click either name above to swap in a different company.

Invesco is the larger business by last-quarter revenue ($1.7B vs $1.7B, roughly 1.0× DuPont). DuPont runs the higher net margin — 9.8% vs -58.9%, a 68.6% gap on every dollar of revenue. On growth, Invesco posted the faster year-over-year revenue change (6.2% vs 4.0%). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs -27.2%).

DuPont de Nemours, Inc., commonly shortened to DuPont, is an American multinational chemical company first formed in 1802 by French-American chemist and industrialist Éleuthère Irénée du Pont de Nemours. The company played a major role in the development of the U.S. state of Delaware and first arose as a major supplier of gunpowder.

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

DD vs IVZ — Head-to-Head

Bigger by revenue
IVZ
IVZ
1.0× larger
IVZ
$1.7B
$1.7B
DD
Growing faster (revenue YoY)
IVZ
IVZ
+2.2% gap
IVZ
6.2%
4.0%
DD
Higher net margin
DD
DD
68.6% more per $
DD
9.8%
-58.9%
IVZ
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
-27.2%
DD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
DD
DD
IVZ
IVZ
Revenue
$1.7B
$1.7B
Net Profit
$164.0M
$-995.9M
Gross Margin
35.8%
Operating Margin
-86.2%
Net Margin
9.8%
-58.9%
Revenue YoY
4.0%
6.2%
Net Profit YoY
-575.8%
EPS (diluted)
$0.36
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DD
DD
IVZ
IVZ
Q1 26
$1.7B
Q4 25
$-2.5B
$1.7B
Q3 25
$3.1B
$1.6B
Q2 25
$3.3B
$1.5B
Q1 25
$3.1B
$1.5B
Q4 24
$3.1B
$1.6B
Q3 24
$3.2B
$1.5B
Q2 24
$3.2B
$1.5B
Net Profit
DD
DD
IVZ
IVZ
Q1 26
$164.0M
Q4 25
$-126.0M
$-995.9M
Q3 25
$-123.0M
$356.4M
Q2 25
$59.0M
$197.4M
Q1 25
$-589.0M
$171.1M
Q4 24
$-118.0M
$209.3M
Q3 24
$454.0M
$55.0M
Q2 24
$178.0M
$132.2M
Gross Margin
DD
DD
IVZ
IVZ
Q1 26
35.8%
Q4 25
Q3 25
38.9%
Q2 25
37.3%
Q1 25
37.4%
Q4 24
36.4%
Q3 24
37.4%
Q2 24
37.1%
Operating Margin
DD
DD
IVZ
IVZ
Q1 26
Q4 25
-86.2%
Q3 25
10.6%
16.5%
Q2 25
9.4%
14.1%
Q1 25
-14.0%
18.1%
Q4 24
1.4%
19.6%
Q3 24
18.4%
6.6%
Q2 24
9.3%
13.9%
Net Margin
DD
DD
IVZ
IVZ
Q1 26
9.8%
Q4 25
4.9%
-58.9%
Q3 25
-4.0%
21.7%
Q2 25
1.8%
13.0%
Q1 25
-19.2%
11.2%
Q4 24
-3.8%
13.1%
Q3 24
14.2%
3.6%
Q2 24
5.6%
8.9%
EPS (diluted)
DD
DD
IVZ
IVZ
Q1 26
$0.36
Q4 25
$-0.30
$-2.61
Q3 25
$-0.29
$0.66
Q2 25
$0.14
$-0.03
Q1 25
$-1.41
$0.38
Q4 24
$-0.28
$0.46
Q3 24
$1.08
$0.12
Q2 24
$0.42
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DD
DD
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$710.0M
$1.0B
Total DebtLower is stronger
$3.2B
$1.8B
Stockholders' EquityBook value
$14.2B
$12.2B
Total Assets
$21.4B
$27.1B
Debt / EquityLower = less leverage
0.22×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DD
DD
IVZ
IVZ
Q1 26
$710.0M
Q4 25
$715.0M
$1.0B
Q3 25
$2.0B
$973.1M
Q2 25
$1.8B
$922.7M
Q1 25
$1.8B
$821.7M
Q4 24
$1.9B
$986.5M
Q3 24
$1.6B
$1.0B
Q2 24
$1.5B
$878.5M
Total Debt
DD
DD
IVZ
IVZ
Q1 26
$3.2B
Q4 25
$3.1B
$1.8B
Q3 25
$7.0B
$1.6B
Q2 25
$5.3B
$1.9B
Q1 25
$5.3B
$964.8M
Q4 24
$5.3B
$890.6M
Q3 24
$7.2B
$890.3M
Q2 24
$7.2B
$890.1M
Stockholders' Equity
DD
DD
IVZ
IVZ
Q1 26
$14.2B
Q4 25
$13.9B
$12.2B
Q3 25
$22.9B
$14.0B
Q2 25
$23.1B
$13.9B
Q1 25
$22.8B
$14.7B
Q4 24
$23.4B
$14.6B
Q3 24
$24.2B
$14.8B
Q2 24
$23.3B
$14.6B
Total Assets
DD
DD
IVZ
IVZ
Q1 26
$21.4B
Q4 25
$21.6B
$27.1B
Q3 25
$38.0B
$28.4B
Q2 25
$36.6B
$28.5B
Q1 25
$36.0B
$28.1B
Q4 24
$36.6B
$27.0B
Q3 24
$37.5B
$27.5B
Q2 24
$36.6B
$27.2B
Debt / Equity
DD
DD
IVZ
IVZ
Q1 26
0.22×
Q4 25
0.23×
0.15×
Q3 25
0.31×
0.12×
Q2 25
0.23×
0.14×
Q1 25
0.23×
0.07×
Q4 24
0.23×
0.06×
Q3 24
0.30×
0.06×
Q2 24
0.31×
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DD
DD
IVZ
IVZ
Operating Cash FlowLast quarter
$455.8M
Free Cash FlowOCF − Capex
$432.2M
FCF MarginFCF / Revenue
25.5%
Capex IntensityCapex / Revenue
6.1%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DD
DD
IVZ
IVZ
Q1 26
Q4 25
$-700.0M
$455.8M
Q3 25
$497.0M
$606.2M
Q2 25
$381.0M
$547.9M
Q1 25
$382.0M
$-84.6M
Q4 24
$564.0M
$316.9M
Q3 24
$737.0M
$438.4M
Q2 24
$527.0M
$489.1M
Free Cash Flow
DD
DD
IVZ
IVZ
Q1 26
Q4 25
$-850.0M
$432.2M
Q3 25
$379.0M
$586.4M
Q2 25
$265.0M
$530.4M
Q1 25
$133.0M
$-108.0M
Q4 24
$403.0M
$309.9M
Q3 24
$628.0M
$410.0M
Q2 24
$425.0M
$462.4M
FCF Margin
DD
DD
IVZ
IVZ
Q1 26
Q4 25
33.4%
25.5%
Q3 25
12.3%
35.7%
Q2 25
8.1%
35.0%
Q1 25
4.3%
-7.1%
Q4 24
13.0%
19.5%
Q3 24
19.7%
27.1%
Q2 24
13.4%
31.2%
Capex Intensity
DD
DD
IVZ
IVZ
Q1 26
6.1%
Q4 25
-5.9%
1.4%
Q3 25
3.8%
1.2%
Q2 25
3.6%
1.2%
Q1 25
8.1%
1.5%
Q4 24
5.2%
0.4%
Q3 24
3.4%
1.9%
Q2 24
3.2%
1.8%
Cash Conversion
DD
DD
IVZ
IVZ
Q1 26
Q4 25
Q3 25
1.70×
Q2 25
6.46×
2.78×
Q1 25
-0.49×
Q4 24
1.51×
Q3 24
1.62×
7.97×
Q2 24
2.96×
3.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DD
DD

Segment breakdown not available.

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons